GO:0004832 | valine-tRNA ligase activity | 8.19e-04 | 1.00e+00 | 10.253 | 1 | 1 | 1 |
GO:0002128 | tRNA nucleoside ribose methylation | 8.19e-04 | 1.00e+00 | 10.253 | 1 | 1 | 1 |
GO:0006438 | valyl-tRNA aminoacylation | 8.19e-04 | 1.00e+00 | 10.253 | 1 | 1 | 1 |
GO:0008175 | tRNA methyltransferase activity | 8.19e-04 | 1.00e+00 | 10.253 | 1 | 1 | 1 |
GO:0001649 | osteoblast differentiation | 1.54e-03 | 1.00e+00 | 5.044 | 2 | 5 | 74 |
GO:0007049 | cell cycle | 3.68e-03 | 1.00e+00 | 4.408 | 2 | 8 | 115 |
GO:2000323 | negative regulation of glucocorticoid receptor signaling pathway | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 5 |
GO:0002161 | aminoacyl-tRNA editing activity | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 1 | 5 |
GO:0070934 | CRD-mediated mRNA stabilization | 4.09e-03 | 1.00e+00 | 7.931 | 1 | 2 | 5 |
GO:0000398 | mRNA splicing, via spliceosome | 4.53e-03 | 1.00e+00 | 4.253 | 2 | 15 | 128 |
GO:0050847 | progesterone receptor signaling pathway | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 2 | 6 |
GO:0002181 | cytoplasmic translation | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 1 | 6 |
GO:0070937 | CRD-mediated mRNA stability complex | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 2 | 6 |
GO:0001055 | RNA polymerase II activity | 4.91e-03 | 1.00e+00 | 7.668 | 1 | 3 | 6 |
GO:0010944 | negative regulation of transcription by competitive promoter binding | 6.54e-03 | 1.00e+00 | 7.253 | 1 | 1 | 8 |
GO:0010388 | cullin deneddylation | 6.54e-03 | 1.00e+00 | 7.253 | 1 | 4 | 8 |
GO:0006450 | regulation of translational fidelity | 6.54e-03 | 1.00e+00 | 7.253 | 1 | 1 | 8 |
GO:0071354 | cellular response to interleukin-6 | 7.35e-03 | 1.00e+00 | 7.083 | 1 | 1 | 9 |
GO:0008380 | RNA splicing | 7.43e-03 | 1.00e+00 | 3.887 | 2 | 21 | 165 |
GO:0010467 | gene expression | 7.44e-03 | 1.00e+00 | 2.775 | 3 | 49 | 535 |
GO:0005736 | DNA-directed RNA polymerase I complex | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 4 | 10 |
GO:0001054 | RNA polymerase I activity | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 4 | 10 |
GO:0005095 | GTPase inhibitor activity | 8.17e-03 | 1.00e+00 | 6.931 | 1 | 1 | 10 |
GO:0060766 | negative regulation of androgen receptor signaling pathway | 8.98e-03 | 1.00e+00 | 6.794 | 1 | 4 | 11 |
GO:0005665 | DNA-directed RNA polymerase II, core complex | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 3 | 13 |
GO:0001056 | RNA polymerase III activity | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 3 | 13 |
GO:0005666 | DNA-directed RNA polymerase III complex | 1.06e-02 | 1.00e+00 | 6.553 | 1 | 3 | 13 |
GO:0006385 | transcription elongation from RNA polymerase III promoter | 1.14e-02 | 1.00e+00 | 6.446 | 1 | 3 | 14 |
GO:0006386 | termination of RNA polymerase III transcription | 1.14e-02 | 1.00e+00 | 6.446 | 1 | 3 | 14 |
GO:0016575 | histone deacetylation | 1.14e-02 | 1.00e+00 | 6.446 | 1 | 2 | 14 |
GO:0000188 | inactivation of MAPK activity | 1.22e-02 | 1.00e+00 | 6.347 | 1 | 1 | 15 |
GO:0005739 | mitochondrion | 1.33e-02 | 1.00e+00 | 2.474 | 3 | 32 | 659 |
GO:0003899 | DNA-directed RNA polymerase activity | 1.47e-02 | 1.00e+00 | 6.083 | 1 | 3 | 18 |
GO:0036464 | cytoplasmic ribonucleoprotein granule | 1.55e-02 | 1.00e+00 | 6.005 | 1 | 1 | 19 |
GO:0071897 | DNA biosynthetic process | 1.63e-02 | 1.00e+00 | 5.931 | 1 | 2 | 20 |
GO:0008180 | COP9 signalosome | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 6 | 24 |
GO:0006370 | 7-methylguanosine mRNA capping | 1.95e-02 | 1.00e+00 | 5.668 | 1 | 5 | 24 |
GO:0006360 | transcription from RNA polymerase I promoter | 2.19e-02 | 1.00e+00 | 5.499 | 1 | 4 | 27 |
GO:0006418 | tRNA aminoacylation for protein translation | 2.35e-02 | 1.00e+00 | 5.395 | 1 | 4 | 29 |
GO:0006383 | transcription from RNA polymerase III promoter | 2.35e-02 | 1.00e+00 | 5.395 | 1 | 6 | 29 |
GO:0007254 | JNK cascade | 2.75e-02 | 1.00e+00 | 5.166 | 1 | 1 | 34 |
GO:0050434 | positive regulation of viral transcription | 2.83e-02 | 1.00e+00 | 5.124 | 1 | 5 | 35 |
GO:0005654 | nucleoplasm | 2.86e-02 | 1.00e+00 | 2.064 | 3 | 68 | 876 |
GO:0006396 | RNA processing | 3.23e-02 | 1.00e+00 | 4.931 | 1 | 4 | 40 |
GO:0006283 | transcription-coupled nucleotide-excision repair | 3.23e-02 | 1.00e+00 | 4.931 | 1 | 6 | 40 |
GO:0032481 | positive regulation of type I interferon production | 3.87e-02 | 1.00e+00 | 4.668 | 1 | 3 | 48 |
GO:0006368 | transcription elongation from RNA polymerase II promoter | 4.18e-02 | 1.00e+00 | 4.553 | 1 | 8 | 52 |
GO:0006289 | nucleotide-excision repair | 4.26e-02 | 1.00e+00 | 4.525 | 1 | 6 | 53 |
GO:0016032 | viral process | 4.50e-02 | 1.00e+00 | 2.512 | 2 | 30 | 428 |
GO:0042826 | histone deacetylase binding | 4.66e-02 | 1.00e+00 | 4.395 | 1 | 5 | 58 |
GO:0071013 | catalytic step 2 spliceosome | 4.89e-02 | 1.00e+00 | 4.323 | 1 | 5 | 61 |
GO:0030308 | negative regulation of cell growth | 5.59e-02 | 1.00e+00 | 4.124 | 1 | 3 | 70 |
GO:0030529 | ribonucleoprotein complex | 6.53e-02 | 1.00e+00 | 3.896 | 1 | 5 | 82 |
GO:0005634 | nucleus | 8.69e-02 | 1.00e+00 | 0.911 | 5 | 158 | 3246 |
GO:0042981 | regulation of apoptotic process | 8.82e-02 | 1.00e+00 | 3.446 | 1 | 4 | 112 |
GO:0044212 | transcription regulatory region DNA binding | 1.11e-01 | 1.00e+00 | 3.094 | 1 | 13 | 143 |
GO:0006367 | transcription initiation from RNA polymerase II promoter | 1.25e-01 | 1.00e+00 | 2.922 | 1 | 18 | 161 |
GO:0004842 | ubiquitin-protein transferase activity | 1.38e-01 | 1.00e+00 | 2.770 | 1 | 17 | 179 |
GO:0016567 | protein ubiquitination | 1.44e-01 | 1.00e+00 | 2.699 | 1 | 14 | 188 |
GO:0005743 | mitochondrial inner membrane | 1.50e-01 | 1.00e+00 | 2.631 | 1 | 9 | 197 |
GO:0006281 | DNA repair | 1.55e-01 | 1.00e+00 | 2.588 | 1 | 24 | 203 |
GO:0019899 | enzyme binding | 1.60e-01 | 1.00e+00 | 2.539 | 1 | 7 | 210 |
GO:0005524 | ATP binding | 1.61e-01 | 1.00e+00 | 1.453 | 2 | 37 | 892 |
GO:0003677 | DNA binding | 1.78e-01 | 1.00e+00 | 1.366 | 2 | 52 | 947 |
GO:0003723 | RNA binding | 1.85e-01 | 1.00e+00 | 2.305 | 1 | 22 | 247 |
GO:0006508 | proteolysis | 1.97e-01 | 1.00e+00 | 2.209 | 1 | 11 | 264 |
GO:0008285 | negative regulation of cell proliferation | 2.06e-01 | 1.00e+00 | 2.140 | 1 | 11 | 277 |
GO:0005515 | protein binding | 2.10e-01 | 1.00e+00 | 0.566 | 5 | 198 | 4124 |
GO:0009986 | cell surface | 2.15e-01 | 1.00e+00 | 2.069 | 1 | 5 | 291 |
GO:0045892 | negative regulation of transcription, DNA-templated | 2.32e-01 | 1.00e+00 | 1.945 | 1 | 17 | 317 |
GO:0006366 | transcription from RNA polymerase II promoter | 2.48e-01 | 1.00e+00 | 1.840 | 1 | 23 | 341 |
GO:0016020 | membrane | 2.59e-01 | 1.00e+00 | 1.016 | 2 | 56 | 1207 |
GO:0045893 | positive regulation of transcription, DNA-templated | 2.70e-01 | 1.00e+00 | 1.695 | 1 | 21 | 377 |
GO:0045087 | innate immune response | 3.16e-01 | 1.00e+00 | 1.433 | 1 | 12 | 452 |
GO:0000122 | negative regulation of transcription from RNA polymerase II promoter | 3.18e-01 | 1.00e+00 | 1.421 | 1 | 29 | 456 |
GO:0005737 | cytoplasm | 3.71e-01 | 1.00e+00 | 0.476 | 3 | 127 | 2633 |
GO:0005887 | integral component of plasma membrane | 3.85e-01 | 1.00e+00 | 1.086 | 1 | 8 | 575 |
GO:0007165 | signal transduction | 4.07e-01 | 1.00e+00 | 0.982 | 1 | 24 | 618 |
GO:0005829 | cytosol | 4.46e-01 | 1.00e+00 | 0.450 | 2 | 88 | 1787 |
GO:0006355 | regulation of transcription, DNA-templated | 4.56e-01 | 1.00e+00 | 0.772 | 1 | 31 | 715 |
GO:0044822 | poly(A) RNA binding | 4.95e-01 | 1.00e+00 | 0.611 | 1 | 45 | 799 |
GO:0070062 | extracellular vesicular exosome | 7.71e-01 | 1.00e+00 | -0.427 | 1 | 51 | 1641 |